首页 | 本学科首页   官方微博 | 高级检索  
     

健择在晚期软组织肉瘤二线治疗中的作用
引用本文:张荣生,刘叙仪. 健择在晚期软组织肉瘤二线治疗中的作用[J]. 大理学院学报:综合版, 2004, 3(5): 91-94
作者姓名:张荣生  刘叙仪
作者单位:1. 大理学院附属医院内科,云南大理,671000
2. 北京大学临床肿瘤学院内科,北京,100036
摘    要:目的 :评价健择治疗晚期软组织肉瘤以阿霉素和异环磷酰胺为基础化疗失败的病人。方法 :对国内外文献进行归纳、分析及总结。结果 :系统阐述该领域在国内外研究现状 ,为今后研究起到指导作用。结论 :健择在晚期软组织肉瘤二线治疗中有较好疗效、化疗毒性可耐受。

关 键 词:健择  晚期软组织肉瘤  药物治疗
文章编号:1672-2345(2004)05-0091-04
修稿时间:2004-01-02

The Effect of Gemcitabine on Second-line Treatment for Patinets with Advanced Soft Tissue Sarcomas
ZHANG Rong- sheng,LU Xu- yi. The Effect of Gemcitabine on Second-line Treatment for Patinets with Advanced Soft Tissue Sarcomas[J]. Journal of Dali University, 2004, 3(5): 91-94
Authors:ZHANG Rong- sheng  LU Xu- yi
Abstract:Objective:To assess the efficacy of gemcitabine in patients with a Variety of advanced soft tissue Sarcomas that have failed to respond or escaped Adriamycin- and ifosfamide- based chemotherapy.Methods:The data of domestic and foreign records were collected and summarized.Results:We systematically elaborated domestic and foreign states about the study,It will guide the further research.Conclusions:The gemcitabine is a highly effective regimen for patients with a variety of advanced soft tissue sarcomas that have failed to respond or escaped Adriamycin- and ifosfamide- based chemotherapy with a manageable toxicity.
Keywords:Gemcitabine  Advanced soft tissue sarcomas  Drug therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号